Low-Dose IFNγ Induces Tumor Cell Stemness in Tumor Microenvironment of Non-Small Cell Lung Cancer.

Abstract:

:IFNγ is conventionally recognized as an inflammatory cytokine that plays a central role in antitumor immunity. Although it has been used clinically to treat a variety of malignancies, low levels of IFNγ in the tumor microenvironment (TME) increase the risk of tumor metastasis during immunotherapy. Accumulating evidence suggests that IFNγ can induce cancer progression, yet the mechanisms underlying the controversial role of IFNγ in tumor development remain unclear. Here, we reveal a dose-dependent effect of IFNγ in inducing tumor stemness to accelerate cancer progression in patients with a variety of cancer types. Low levels of IFNγ endowed cancer stem-like properties via the intercellular adhesion molecule-1 (ICAM1)-PI3K-Akt-Notch1 axis, whereas high levels of IFNγ activated the JAK1-STAT1-caspase pathway to induce apoptosis in non-small cell lung cancer (NSCLC). Inhibition of ICAM1 abrogated the stem-like properties of NSCLC cells induced by the low dose of IFNγ both in vitro and in vivo. This study unveils the role of low levels of IFNγ in conferring tumor stemness and elucidates the distinct signaling pathways activated by IFNγ in a dose-dependent manner, thus providing new insights into cancer treatment, particularly for patients with low expression of IFNγ in the TME. SIGNIFICANCE: These findings reveal the dose-dependent effect of IFNγ in inducing tumor stemness and elucidate the distinct molecular mechanisms activated by IFNγ in a dose-dependent manner.

journal_name

Cancer Res

journal_title

Cancer research

authors

Song M,Ping Y,Zhang K,Yang L,Li F,Zhang C,Cheng S,Yue D,Maimela NR,Qu J,Liu S,Sun T,Li Z,Xia J,Zhang B,Wang L,Zhang Y

doi

10.1158/0008-5472.CAN-19-0596

subject

Has Abstract

pub_date

2019-07-15 00:00:00

pages

3737-3748

issue

14

eissn

0008-5472

issn

1538-7445

pii

0008-5472.CAN-19-0596

journal_volume

79

pub_type

杂志文章
  • Phase I-II study of epirubicin in multiple myeloma.

    abstract::Forty patients with relapsed (26) or refractory (14) myeloma were treated with epirubicin of doses of 75, 90, 105, and 120 mg/m2 in groups of 6 or more patients to test for response, maximum tolerated dose, and toxicity. Thirteen patients had received prior doxorubicin and were included in the dose findings part of th...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Case DC Jr,Ervin TJ,Gams R,Sonneborn HL,Paul SD,Oldham FB

    更新日期:1988-11-01 00:00:00

  • Purines, purinergic receptors, and cancer.

    abstract::Purines were long thought to be restricted to the intracellular compartment, where they are used for energy transactions, nucleic acid synthesis, and a multiplicity of biochemical reactions. However, it is now clear that both adenosine and adenosine triphosphate are (i) abundant biochemical components of the tumor mic...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:10.1158/0008-5472.CAN-12-1600

    authors: Di Virgilio F

    更新日期:2012-11-01 00:00:00

  • Human lung carcinomas express Fas ligand.

    abstract::To reach a clinically detectable size, neoplasms must be able to suppress or evade a host immune response. Activated T cells may enter apoptosis in the presence of Fas ligand (FasL) (1), and tissue expression of FasL has been shown to contribute to immune privilege in the eye and testis (2, 3). We have demonstrated th...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Niehans GA,Brunner T,Frizelle SP,Liston JC,Salerno CT,Knapp DJ,Green DR,Kratzke RA

    更新日期:1997-03-15 00:00:00

  • Increased expression of the E3 ubiquitin ligase RNF5 is associated with decreased survival in breast cancer.

    abstract::The selective ubiquitination of proteins by ubiquitin E3 ligases plays an important regulatory role in control of cell differentiation, growth, and transformation and their dysregulation is often associated with pathologic outcomes, including tumorigenesis. RNF5 is an E3 ubiquitin ligase that has been implicated in mo...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-0045

    authors: Bromberg KD,Kluger HM,Delaunay A,Abbas S,DiVito KA,Krajewski S,Ronai Z

    更新日期:2007-09-01 00:00:00

  • Trafficking of nuclear heparin-binding epidermal growth factor-like growth factor into an epidermal growth factor receptor-dependent autocrine loop in response to oxidative stress.

    abstract::Heparin-binding epidermal growth factor (EGF)-like growth factor (HB-EGF) accumulates in the nucleus in aggressive transitional cell carcinoma (TCC) cells and this histologic feature is a marker of poor prognosis in human bladder cancer tissues. Here we report that HB-EGF can be exported from the nucleus during stimul...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-0942

    authors: Kim J,Adam RM,Freeman MR

    更新日期:2005-09-15 00:00:00

  • Characterization of liver-type alkaline phosphatase from human gastric carcinoma cells (KMK-2) in vitro.

    abstract::Alkaline phosphatase was extracted from human gastric carcinoma cells (KMK-2) under long-term culture, and its biochemical and biological properties were investigated. The enzyme was extremely heat labile and was inhibited significantly by L-homoarginine, but only slightly by L-phenylalanine, so that it was classified...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Tokumitsu SI,Tokumitsu K,Kohnoe K,Takeuchi T

    更新日期:1979-11-01 00:00:00

  • An enzyme-linked immunosorbent assay for cancer procoagulant and its potential as a new tumor marker.

    abstract::Cancer procoagulant (CP) is a Mr 68,000 cysteine proteinase that initiates blood coagulation and is expressed by a variety of malignant cells but not by normally differentiated cells. Polyclonal immunoglobulin G and monoclonal immunoglobulin M antibodies were developed to purified CP and used to develop an enzyme-link...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Gordon SG,Cross BA

    更新日期:1990-10-01 00:00:00

  • Phospholipase D prevents etoposide-induced apoptosis by inhibiting the expression of early growth response-1 and phosphatase and tensin homologue deleted on chromosome 10.

    abstract::Phospholipase D (PLD) has emerged as a critical regulator of cell proliferation and survival signaling. We show for the first time that elevated expression of PLD isozymes attenuates expression of the tumor suppressors early growth response-1 (Egr-1) and the phosphatase and tensin homologue deleted on chromosome 10 (P...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-1316

    authors: Kim J,Lee YH,Kwon TK,Chang JS,Chung KC,Min DS

    更新日期:2006-01-15 00:00:00

  • Cross-reactivity between Bacillus Calmette-Guérin and Rous Virus-induced sarcoma detected in rats by tube leukocyte adherence inhibition assay.

    abstract::Specific immunity to Rous virus-induced sarcoma (RSL) was investigated by the tube leukocyte adherence inhibition (LAI) assay in rats immunized with Bacillus Calmette-Guérin (BCG). Peritoneal cells from Lewis rats immunized s.c. with BCG gave positive reactions in the tube LAI assay with the antigen prepared from RSL ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Holán V,Chutná J,Hasek M

    更新日期:1979-02-01 00:00:00

  • Nitric oxide in physiologic concentrations targets the translational machinery to increase the proliferation of human breast cancer cells: involvement of mammalian target of rapamycin/eIF4E pathway.

    abstract::Nitric oxide (NO) in nanomolar (nmol/L) concentrations is consistently detected in tumor microenvironment and has been found to promote tumorigenesis. The mechanism by which NO enhances tumor progression is largely unknown. In this study, we investigated the possible mechanisms and identified cellular targets by which...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-4623

    authors: Pervin S,Singh R,Hernandez E,Wu G,Chaudhuri G

    更新日期:2007-01-01 00:00:00

  • Enhancing poxvirus oncolytic effects through increased spread and immune evasion.

    abstract::The antitumoral effects of oncolytic viruses have generally been limited by inefficient spread of the viruses within infected tumors and by inefficient systemic delivery, particularly in preimmunized hosts. Tumor-selective poxviruses have biological characteristics that may overcome these limitations. Nevertheless, ph...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-6515

    authors: Kirn DH,Wang Y,Liang W,Contag CH,Thorne SH

    更新日期:2008-04-01 00:00:00

  • FoxM1 in tumorigenicity of the neuroblastoma cells and renewal of the neural progenitors.

    abstract::Malignant neuroblastomas contain stem-like cells. These tumors also overexpress the Forkhead box transcription factor FoxM1. In this study, we investigated the roles of FoxM1 in the tumorigenicity of neuroblastoma. We showed that depletion of FoxM1 inhibits anchorage-independent growth and tumorigenicity in mouse xeno...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-10-4087

    authors: Wang Z,Park HJ,Carr JR,Chen YJ,Zheng Y,Li J,Tyner AL,Costa RH,Bagchi S,Raychaudhuri P

    更新日期:2011-06-15 00:00:00

  • Long-term XPC silencing reduces DNA double-strand break repair.

    abstract::To study the relationships between different DNA repair pathways, we established a set of clones in which one specific DNA repair gene was silenced using long-term RNA interference in HeLa cell line. We focus here on genes involved in either nucleotide excision repair (XPA and XPC) or nonhomologous end joining (NHEJ; ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-3371

    authors: Despras E,Pfeiffer P,Salles B,Calsou P,Kuhfittig-Kulle S,Angulo JF,Biard DS

    更新日期:2007-03-15 00:00:00

  • Retroviral insertional mutagenesis as a strategy for the identification of genes associated with cis-diamminedichloroplatinum(II) resistance.

    abstract::Expression of resistance to cis-diamminedichloroplatinum(II) (CDDP), one of the most effective chemotherapeutic drugs used to treat a variety of malignancies, remains a serious obstacle for improving cancer treatment. To study possible genetic mechanisms underlying the development of CDDP resistance, we have adopted t...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Lu SJ,Man S,Bani MR,Adachi D,Hawley RG,Kerbel RS,Ben-David Y

    更新日期:1995-03-01 00:00:00

  • Live attenuated Listeria monocytogenes effectively treats hepatic colorectal cancer metastases and is strongly enhanced by depletion of regulatory T cells.

    abstract::The liver represents a major and frequently sole site of metastases for many types of cancer, particularly gastrointestinal cancers. We showed previously that coadministration of an engineered hepatic-targeting Listeria monocytogenes (LM) with a cancer vaccine enhanced the antitumor effect of vaccine-induced T cells s...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-0573

    authors: Yoshimura K,Laird LS,Chia CY,Meckel KF,Slansky JE,Thompson JM,Jain A,Pardoll DM,Schulick RD

    更新日期:2007-10-15 00:00:00

  • A 27-amino-acid synthetic peptide corresponding to the NH2-terminal zinc-binding domain of endostatin is responsible for its antitumor activity.

    abstract::The first recombinant endostatin that elicited strong antitumor activity was expressed in Escherichia coli and administered as a suspension. Under these conditions, the protein retained its full antiangiogenic activity. Lack of requirement for a folded structure prompted us to investigate antitumor properties of synth...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-04-1833

    authors: Tjin Tham Sjin RM,Satchi-Fainaro R,Birsner AE,Ramanujam VM,Folkman J,Javaherian K

    更新日期:2005-05-01 00:00:00

  • TSP50 encodes a testis-specific protease and is negatively regulated by p53.

    abstract::Earlier studies suggested that TSP50 is a testis-specific gene that encodes a protein, which is homologous to serine proteases but differs in that threonine replaces serine in its catalytic triad. Most importantly, it was abnormally reactivated in many breast cancer biopsies tested. While further investigating its bio...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-3688

    authors: Xu H,Shan J,Jurukovski V,Yuan L,Li J,Tian K

    更新日期:2007-02-01 00:00:00

  • Unraveling the "known unknowns": lessons and reflections from the new directions in leukemia research 2012 conference.

    abstract::Patients diagnosed with leukemia approach their treatment with the hope of cure despite the effect on their quality of life. Some patients will be cured, others will die from treatment, and some will die of their disease. A common theme at the New Directions in Leukemia Research (NDLR 2012) meeting was that cure will ...

    journal_title:Cancer research

    pub_type:

    doi:10.1158/0008-5472.CAN-12-1832

    authors: White DL,Brown AL,D'Andrea RJ,Rice AM

    更新日期:2012-09-01 00:00:00

  • Limitation of differential expression of HLA-A,B,C antigens on choriocarcinoma cell lines by messenger RNA for HLA heavy chain but not by beta 2-microglobulin.

    abstract::The relative amounts of HLA-A,B,C antigens, beta 2-microglobulin (beta 2m), and trophoblast antigens (Trop-1 and Trop-2) were determined on nine choriocarcinoma cell lines including seven lines of gestational origin and two lines of nongestational origin (from ovary and stomach) by quantitative immunofluorescence anal...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Kawata M,Sizer K,Sekiya S,Parnes JR,Herzenberg LA

    更新日期:1984-09-01 00:00:00

  • Antiangiogenic strategies on defense: on the possibility of blocking rebounds by the tumor vasculature after chemotherapy.

    abstract::Rapid or accelerated tumor cell repopulation after significant tumor cell killing induced by various cytotoxic agents often compromises the expected therapeutic benefit of such tumor responses. Here, we discuss the concept that tumor cell repopulation after certain cytotoxic therapies, using vascular disrupting agents...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:10.1158/0008-5472.CAN-07-0905

    authors: Shaked Y,Kerbel RS

    更新日期:2007-08-01 00:00:00

  • RhoC promotes metastasis via activation of the Pyk2 pathway in prostate cancer.

    abstract::RhoC is a member of the Ras-homologous family of genes which have been implicated in tumorigenesis and tumor progression. However, the exact role of RhoC is controversial and is yet to be clarified. We have examined the effect of RhoC on prostate tumor cells and found that RhoC had no effect on cell proliferation in v...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-6700

    authors: Iiizumi M,Bandyopadhyay S,Pai SK,Watabe M,Hirota S,Hosobe S,Tsukada T,Miura K,Saito K,Furuta E,Liu W,Xing F,Okuda H,Kobayashi A,Watabe K

    更新日期:2008-09-15 00:00:00

  • Mouse models of human cancer consortium symposium on nervous system tumors.

    abstract::Nervous system tumors represent unique neoplasms that arise within the central and peripheral nervous system. Recent progress in generating genetically engineered mouse models of these tumors has advanced our understanding of the critical molecular and cellular events important for the development of these tumors. Rec...

    journal_title:Cancer research

    pub_type:

    doi:

    authors: Gutmann DH,Baker SJ,Giovannini M,Garbow J,Weiss W

    更新日期:2003-06-01 00:00:00

  • Mechanistic investigation and implications of photodynamic therapy induction of vascular endothelial growth factor in prostate cancer.

    abstract::Photodynamic therapy (PDT) is now an approved therapeutic modality, and induction of vascular endothelial growth factor (VEGF) following subcurative PDT is of concern as VEGF may provide a survival stimulus to tumors. The processes that limit the efficacy of PDT warrant investigation so that mechanism-based interventi...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-0604

    authors: Solban N,Selbo PK,Sinha AK,Chang SK,Hasan T

    更新日期:2006-06-01 00:00:00

  • Docetaxel chronopharmacology in mice.

    abstract::Docetaxel tolerance and antitumor efficacy could be enhanced if drug administration was adapted to circadian rhythms. This hypothesis was investigated in seven experiments involving a total of 626 male B6D2F1 mice, synchronized with an alternation of 12 h of light and 12 h of darkness (12:12), after i.v. administratio...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Tampellini M,Filipski E,Liu XH,Lemaigre G,Li XM,Vrignaud P,François E,Bissery MC,Lévi F

    更新日期:1998-09-01 00:00:00

  • Inactivation of 1,3-, 1,6-, and 1,8-dinitropyrene by cytochrome P-450 enzymes in human and rat liver microsomes.

    abstract::NADPH-fortified human liver microsomes were examined with regard to ability to detoxicate several chemicals that do not require enzymatic oxidation to elicit a genotoxic response in a Salmonella typhimurium TA1535/pSK1002 system where umu response is used as an indicator of DNA damage. Microsomes did not affect the re...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Shimada T,Guengerich FP

    更新日期:1990-04-01 00:00:00

  • Development of novel ADCs: conjugation of tubulysin analogues to trastuzumab monitored by dual radiolabeling.

    abstract::Tubulysins are highly toxic tubulin-targeting agents with a narrow therapeutic window that are interesting for application in antibody-drug conjugates (ADC). For full control over drug-antibody ratio (DAR) and the effect thereof on pharmacokinetics and tumor targeting, a dual-labeling approach was developed, wherein t...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-14-1141

    authors: Cohen R,Vugts DJ,Visser GW,Stigter-van Walsum M,Bolijn M,Spiga M,Lazzari P,Shankar S,Sani M,Zanda M,van Dongen GA

    更新日期:2014-10-15 00:00:00

  • Inhibition of transformation of primary rat tracheal epithelial cells by retinoic acid.

    abstract::The effect of retinoic acid (RA) on N-methyl-N'-nitro-N-nitrosoguanidine-induced transformation of primary cultures of rat tracheal epithelial cells was investigated. RA inhibited transformation of rat tracheal epithelial cells by up to 95% at concentrations of 3.3 to 33 nM which did not substantially affect cell surv...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Mass MJ,Nettesheim P,Beeman DK,Barrett JC

    更新日期:1984-12-01 00:00:00

  • Effects of high hoses of estrogen on prolactin-binding activity and growth of carcinogen-induced mammary cancers in rats.

    abstract::Specific binding sites for prolactin (PRL) were present in membrane preparations from 7,12-dimethylbenz(a)-anthracene-induced rat mammary tumors. The specific binding of PRL was time and temperature dependent. A significant negative correlation was noted between administered doses of estrogen and the subsequent bindin...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Kledzik GS,Bradley CJ,Marshall S,Campbell GA,Meites J

    更新日期:1976-09-01 00:00:00

  • Urea as a recovery marker for quantitative assessment of tumor interstitial solutes with microdialysis.

    abstract::Microdialysis is a technique that enables measurement of extracellular concentrations of unbound analytes. A small probe with a semipermeable membrane is implanted in tissue and constantly perfused. Small analytes in the interstitial fluid diffuse into the perfusate and are collected. Often, microdialysate concentrati...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ettinger SN,Poellmann CC,Wisniewski NA,Gaskin AA,Shoemaker JS,Poulson JM,Dewhirst MW,Klitzman B

    更新日期:2001-11-01 00:00:00

  • Treatment of prostate cancer in the rat with the synthetic retinoid fenretinide.

    abstract::N-4-Hydroxyphenylretinamide (fenretinide or 4HPR), a derivative of retinoic acid, has been demonstrated to decrease the development of prostate cancer in a rat carcinogenesis model. This study was undertaken to determine if 4HPR is an effective agent for the treatment of established prostate cancer. In vitro, 4HPR was...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Pienta KJ,Nguyen NM,Lehr JE

    更新日期:1993-01-15 00:00:00